Therefore, in sPLA2-IID-deficient mice, Th1-driven CHS and Th17-driven psoriasis are exacerbated, whereas skin cancer is attenuated because of enhanced anti-tumor immunity [84]. This evidence concerns the gene LYST and skin neoplasm.